Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
A Randomized Phase III Trial of Three Different Regimens of CPT-11 Plus 5-Fluorouracil and Leucovorin Compared to 5-Fluorouracil and Leucovorin in Patients With Advanced Adenocarcinoma of the Colon and Rectum
Status: Enrolling
Updated:  7/9/2015
Waukesha Memorial Hospital
871
mi
from 02139
Waukesha, WI
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
A Randomized Phase III Trial of Three Different Regimens of CPT-11 Plus 5-Fluorouracil and Leucovorin Compared to 5-Fluorouracil and Leucovorin in Patients With Advanced Adenocarcinoma of the Colon and Rectum
Status: Enrolling
Updated: 7/9/2015
Waukesha Memorial Hospital
871
mi
from 02139
Waukesha, WI
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
A Randomized Phase III Trial of Three Different Regimens of CPT-11 Plus 5-Fluorouracil and Leucovorin Compared to 5-Fluorouracil and Leucovorin in Patients With Advanced Adenocarcinoma of the Colon and Rectum
Status: Enrolling
Updated:  7/9/2015
UW Cancer Center Wausau Hospital
941
mi
from 02139
Wausau, WI
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
A Randomized Phase III Trial of Three Different Regimens of CPT-11 Plus 5-Fluorouracil and Leucovorin Compared to 5-Fluorouracil and Leucovorin in Patients With Advanced Adenocarcinoma of the Colon and Rectum
Status: Enrolling
Updated: 7/9/2015
UW Cancer Center Wausau Hospital
941
mi
from 02139
Wausau, WI
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
A Randomized Phase III Trial of Three Different Regimens of CPT-11 Plus 5-Fluorouracil and Leucovorin Compared to 5-Fluorouracil and Leucovorin in Patients With Advanced Adenocarcinoma of the Colon and Rectum
Status: Enrolling
Updated:  7/9/2015
Cross Cancer Institute
2070
mi
from 02139
Edmonton,
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
A Randomized Phase III Trial of Three Different Regimens of CPT-11 Plus 5-Fluorouracil and Leucovorin Compared to 5-Fluorouracil and Leucovorin in Patients With Advanced Adenocarcinoma of the Colon and Rectum
Status: Enrolling
Updated: 7/9/2015
Cross Cancer Institute
2070
mi
from 02139
Edmonton,
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Scottsdale Oncology Program
2274
mi
from 02139
Scottsdale, AZ
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Scottsdale Oncology Program
2274
mi
from 02139
Scottsdale, AZ
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
Mayo Clinic
1018
mi
from 02139
Jacksonville, FL
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
Mayo Clinic
1018
mi
from 02139
Jacksonville, FL
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Atlanta Regional
927
mi
from 02139
Atlanta, GA
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Atlanta Regional
927
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
MBCCOP - Hawaii
5078
mi
from 02139
Honolulu, HI
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
MBCCOP - Hawaii
5078
mi
from 02139
Honolulu, HI
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Illinois Oncology Research Association
961
mi
from 02139
Peoria, IL
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Illinois Oncology Research Association
961
mi
from 02139
Peoria, IL
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Carle Cancer Center
900
mi
from 02139
Urbana, IL
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Carle Cancer Center
900
mi
from 02139
Urbana, IL
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Cedar Rapids Oncology Project
1048
mi
from 02139
Cedar Rapids, IA
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Cedar Rapids Oncology Project
1048
mi
from 02139
Cedar Rapids, IA
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Iowa Oncology Research Association
1154
mi
from 02139
Des Moines, IA
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Iowa Oncology Research Association
1154
mi
from 02139
Des Moines, IA
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
Siouxland Hematology-Oncology
1285
mi
from 02139
Sioux City, IA
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
Siouxland Hematology-Oncology
1285
mi
from 02139
Sioux City, IA
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Wichita
1417
mi
from 02139
Wichita, KA
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Wichita
1417
mi
from 02139
Wichita, KA
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Duluth
1073
mi
from 02139
Duluth, MN
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Duluth
1073
mi
from 02139
Duluth, MN
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
Mayo Clinic Cancer Center
1079
mi
from 02139
Rochester, MN
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
Mayo Clinic Cancer Center
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
Medcenter One Health System
1483
mi
from 02139
Bismarck, ND
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
Medcenter One Health System
1483
mi
from 02139
Bismarck, ND
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Toledo Community Hospital
640
mi
from 02139
Toledo, OH
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Toledo Community Hospital
640
mi
from 02139
Toledo, OH
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Geisinger Clinic and Medical Center
299
mi
from 02139
Danville, PA
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Geisinger Clinic and Medical Center
299
mi
from 02139
Danville, PA
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Sioux Community Cancer Consortium
1293
mi
from 02139
Sioux Falls, SD
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Sioux Community Cancer Consortium
1293
mi
from 02139
Sioux Falls, SD
Click here to add this to my saved trials
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated:  7/9/2015
Allan Blair Cancer Centre
1674
mi
from 02139
Regina,
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Status: Enrolling
Updated: 7/9/2015
Allan Blair Cancer Centre
1674
mi
from 02139
Regina,
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Scottsdale Oncology Program
2274
mi
from 02139
Scottsdale, AZ
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Scottsdale Oncology Program
2274
mi
from 02139
Scottsdale, AZ
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Carle Cancer Center
900
mi
from 02139
Urbana, IL
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Carle Cancer Center
900
mi
from 02139
Urbana, IL
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Cedar Rapids Oncology Project
1048
mi
from 02139
Cedar Rapids, IA
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Cedar Rapids Oncology Project
1048
mi
from 02139
Cedar Rapids, IA
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Iowa Oncology Research Association
1154
mi
from 02139
Des Moines, IA
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Iowa Oncology Research Association
1154
mi
from 02139
Des Moines, IA
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
Siouxland Hematology-Oncology
1285
mi
from 02139
Sioux City, IA
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
Siouxland Hematology-Oncology
1285
mi
from 02139
Sioux City, IA
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Wichita
1417
mi
from 02139
Wichita, KA
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Wichita
1417
mi
from 02139
Wichita, KA
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Duluth
1073
mi
from 02139
Duluth, MN
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Duluth
1073
mi
from 02139
Duluth, MN
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
Mayo Clinic Cancer Center
1079
mi
from 02139
Rochester, MN
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
Mayo Clinic Cancer Center
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
CentraCare Clinic
1165
mi
from 02139
Saint Cloud, MN
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
CentraCare Clinic
1165
mi
from 02139
Saint Cloud, MN
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Missouri Valley Cancer Consortium
1279
mi
from 02139
Omaha, NE
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Missouri Valley Cancer Consortium
1279
mi
from 02139
Omaha, NE
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
Medcenter One Health System
1483
mi
from 02139
Bismarck, ND
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
Medcenter One Health System
1483
mi
from 02139
Bismarck, ND
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Merit Care Hospital
1294
mi
from 02139
Fargo, ND
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Merit Care Hospital
1294
mi
from 02139
Fargo, ND
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Toledo Community Hospital Oncology Program
644
mi
from 02139
Toledo, OH
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Toledo Community Hospital Oncology Program
644
mi
from 02139
Toledo, OH
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Geisinger Clinic and Medical Center
299
mi
from 02139
Danville, PA
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Geisinger Clinic and Medical Center
299
mi
from 02139
Danville, PA
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
Rapid City Regional Hospital
1610
mi
from 02139
Rapid City, SD
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
Rapid City Regional Hospital
1610
mi
from 02139
Rapid City, SD
Click here to add this to my saved trials
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Sioux Community Cancer Consortium
1293
mi
from 02139
Sioux Falls, SD
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Sioux Community Cancer Consortium
1293
mi
from 02139
Sioux Falls, SD
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Scottsdale Oncology Program
2274
mi
from 02139
Scottsdale, AZ
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Scottsdale Oncology Program
2274
mi
from 02139
Scottsdale, AZ
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
Mayo Clinic, Jacksonville
1016
mi
from 02139
Jacksonville, FL
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
Mayo Clinic, Jacksonville
1016
mi
from 02139
Jacksonville, FL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Illinois Oncology Research Association
961
mi
from 02139
Peoria, IL
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Illinois Oncology Research Association
961
mi
from 02139
Peoria, IL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Carle Cancer Center
900
mi
from 02139
Urbana, IL
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Carle Cancer Center
900
mi
from 02139
Urbana, IL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Cedar Rapids Oncology Project
1048
mi
from 02139
Cedar Rapids, IA
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Cedar Rapids Oncology Project
1048
mi
from 02139
Cedar Rapids, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Iowa Oncology Research Association
1154
mi
from 02139
Des Moines, IA
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Iowa Oncology Research Association
1154
mi
from 02139
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
Siouxland Hematology-Oncology
1285
mi
from 02139
Sioux City, IA
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
Siouxland Hematology-Oncology
1285
mi
from 02139
Sioux City, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Wichita
1417
mi
from 02139
Wichita, KA
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Wichita
1417
mi
from 02139
Wichita, KA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Ann Arbor Regional
646
mi
from 02139
Ann Arbor, MI
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Ann Arbor Regional
646
mi
from 02139
Ann Arbor, MI
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Duluth
1073
mi
from 02139
Duluth, MN
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Duluth
1073
mi
from 02139
Duluth, MN
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
Mayo Clinic Cancer Center
1079
mi
from 02139
Rochester, MN
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
Mayo Clinic Cancer Center
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
CentraCare Clinic
1165
mi
from 02139
Saint Cloud, MN
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
CentraCare Clinic
1165
mi
from 02139
Saint Cloud, MN
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Metro-Minnesota
1122
mi
from 02139
Saint Louis Park, MN
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Metro-Minnesota
1122
mi
from 02139
Saint Louis Park, MN
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated:  7/9/2015
CCOP - Missouri Valley Cancer Consortium
1279
mi
from 02139
Omaha, NE
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Phase II Trial Of Gemcitabine, 5-Fluorouracil, And Leucovorin In Patients With Measurable Unresectable Or Metastatic Biliary Tract Carcinoma (Intrahepatic, Extrahepatic, Ampulla Of Vater) And Gallbladder Carcinoma
Status: Enrolling
Updated: 7/9/2015
CCOP - Missouri Valley Cancer Consortium
1279
mi
from 02139
Omaha, NE
Click here to add this to my saved trials